These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 17094436)
41. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody. Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971 [TBL] [Abstract][Full Text] [Related]
43. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy. Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791 [TBL] [Abstract][Full Text] [Related]
44. Structural characteristics for biological activity of heat-stable enterotoxin produced by enterotoxigenic Escherichia coli: X-ray crystallography of weakly toxic and nontoxic analogs. Sato T; Ozaki H; Hata Y; Kitagawa Y; Katsube Y; Shimonishi Y Biochemistry; 1994 Jul; 33(29):8641-50. PubMed ID: 8038153 [TBL] [Abstract][Full Text] [Related]
45. H4octapa: an acyclic chelator for 111In radiopharmaceuticals. Price EW; Cawthray JF; Bailey GA; Ferreira CL; Boros E; Adam MJ; Orvig C J Am Chem Soc; 2012 May; 134(20):8670-83. PubMed ID: 22540281 [TBL] [Abstract][Full Text] [Related]
46. Localization of indium-111 in human malignant tumor xenografts and control by chelators. Watanabe N; Oriuchi N; Endo K; Inoue T; Tanada S; Murata H; Kim EE; Sasaki Y Nucl Med Biol; 1999 Oct; 26(7):853-8. PubMed ID: 10628568 [TBL] [Abstract][Full Text] [Related]
47. Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer? Carrithers SL Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3018-20. PubMed ID: 12631696 [No Abstract] [Full Text] [Related]
48. Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. Kaloudi A; Nock BA; Lymperis E; Krenning EP; de Jong M; Maina T Cancer Biother Radiopharm; 2016 Feb; 31(1):20-8. PubMed ID: 26844849 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of radiolabeled type IV collagen fragments as potential tumor imaging agents. Edwards WB; Anderson CJ; Fields GB; Welch MJ Bioconjug Chem; 2001; 12(6):1057-65. PubMed ID: 11716700 [TBL] [Abstract][Full Text] [Related]
50. [111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study. Tatsi A; Maina T; Cescato R; Waser B; Krenning EP; de Jong M; Cordopatis P; Reubi JC; Nock BA EJNMMI Res; 2012 Jun; 2(1):25. PubMed ID: 22682002 [TBL] [Abstract][Full Text] [Related]
51. Radiolabeling of bleomycin-glucuronide with (131)I and biodistribution studies using xenograft model of human colon tumor in Balb/C mice. Demiroğlu H; Avcibaşi U; Ünak P; Müftüler FZ; İçhedef ÇA; Gümüşer FG; Sakarya S Cancer Biother Radiopharm; 2012 Aug; 27(6):371-83. PubMed ID: 22690908 [TBL] [Abstract][Full Text] [Related]
52. A Multifunctional Radiotheranostic Agent for Dual Targeting of Breast Cancer Cells. Vultos F; Fernandes C; Mendes F; Marques F; Correia JDG; Santos I; Gano L ChemMedChem; 2017 Jul; 12(14):1103-1107. PubMed ID: 28628723 [TBL] [Abstract][Full Text] [Related]
53. Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue. Chini B; Chinol M; Cassoni P; Papi S; Reversi A; Areces L; Marrocco T; Paganelli G; Manning M; Bussolati G Br J Cancer; 2003 Sep; 89(5):930-6. PubMed ID: 12942128 [TBL] [Abstract][Full Text] [Related]
54. Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s. Gaertner FC; Luxenhofer R; Blechert B; Jordan R; Essler M J Control Release; 2007 Jun; 119(3):291-300. PubMed ID: 17451833 [TBL] [Abstract][Full Text] [Related]
55. Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation. Kaloudi A; Nock BA; Lymperis E; Valkema R; Krenning EP; de Jong M; Maina T EJNMMI Res; 2016 Dec; 6(1):15. PubMed ID: 26882895 [TBL] [Abstract][Full Text] [Related]
56. Internalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localization. Urizzi P; Souchard JP; Palevody C; Ratovo G; Hollande E; Nepveu F Int J Cancer; 1997 Jan; 70(3):315-22. PubMed ID: 9033634 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, Radiolabeling, and Bioevaluation of Bis(Trifluoromethanesulfonyl) Imide. Ersöz OA; Soylu HM; Er O; Ocakoglu K; Lambrecht FY; Yilmaz O Cancer Biother Radiopharm; 2015 Nov; 30(9):395-9. PubMed ID: 26560195 [TBL] [Abstract][Full Text] [Related]
58. Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent. Nakashima K; Iikuni S; Watanabe H; Ono M Chem Commun (Camb); 2021 Jun; 57(52):6432-6435. PubMed ID: 34095905 [TBL] [Abstract][Full Text] [Related]
59. Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C. Weiglmeier PR; Rösch P; Berkner H Toxins (Basel); 2010 Sep; 2(9):2213-29. PubMed ID: 22069681 [TBL] [Abstract][Full Text] [Related]